Exos Asset Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Exos Asset Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$422K	Sell	43,301 -9,496	-18%	-$92.7K	0.22%	116
2022 Q1	$514K	Buy	52,797 +1,760	+3%	+$17.1K	0.22%	121
2021 Q4	$494K	Sell	51,037 -3,963	-7%	-$38.9K	0.25%	121
2021 Q3	$531K	Buy	+55,000	New	+$537K	0.28%	111

Other funds holding ORIA

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Exos Asset Management's ORIA Position: Q2 2022 in Review

Exos Asset Management reduced its Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) stake by 18% in Q2 2022, selling an estimated $92.7K and leaving 43,301 shares worth $422K. The position accounts for 0.22% of the portfolio, ranked #116.

Exos Asset Management first reported a position in ORIA in Q3 2021 and has held it in 4 quarters since. The position peaked at $531K in Q3 2021. 48 funds tracked by Wall St. Rank hold ORIA as of Q2 2022.

Exos Asset Management held 43,301 shares of Orion Biotech Opportunities Corp. Class A Ordinary Share worth $422K as of Q2 2022.
Exos Asset Management sold 9,496 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2022, an estimated $92.7K.
Orion Biotech Opportunities Corp. Class A Ordinary Share made up 0.22% of Exos Asset Management's portfolio in Q2 2022, its #116 holding.
Exos Asset Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and has held it in 4 quarters since.
Exos Asset Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $531K in Q3 2021.
48 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.